Search

Search Constraints

You searched for: Author/Creator Eufemon Cereno, Reno

Search Results

1. Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial. (May 2023)